253 related articles for article (PubMed ID: 20826539)
1. Naive and activated T cells display differential responsiveness to TL1A that affects Th17 generation, maintenance, and proliferation.
Jones GW; Stumhofer JS; Foster T; Twohig JP; Hertzog P; Topley N; Williams AS; Hunter CA; Jenkins BJ; Wang EC; Jones SA
FASEB J; 2011 Jan; 25(1):409-19. PubMed ID: 20826539
[TBL] [Abstract][Full Text] [Related]
2. TL1A increased the differentiation of peripheral Th17 in rheumatoid arthritis.
Zhou M; Liu R; Su D; Feng X; Li X
Cytokine; 2014 Sep; 69(1):125-30. PubMed ID: 24832108
[TBL] [Abstract][Full Text] [Related]
3. TL1A and DR3, a TNF family ligand-receptor pair that promotes lymphocyte costimulation, mucosal hyperplasia, and autoimmune inflammation.
Meylan F; Richard AC; Siegel RM
Immunol Rev; 2011 Nov; 244(1):188-96. PubMed ID: 22017439
[TBL] [Abstract][Full Text] [Related]
4. Tumor Necrosis Factor-like Cytokine TL1A and Its Receptors DR3 and DcR3: Important New Factors in Mucosal Homeostasis and Inflammation.
Siakavellas SI; Bamias G
Inflamm Bowel Dis; 2015 Oct; 21(10):2441-52. PubMed ID: 26099067
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of DR3 expression in CD4⁺ T cells promotes secretion of IL-17 in experimental autoimmune uveitis.
Qin T
Mol Vis; 2011; 17():3486-93. PubMed ID: 22219644
[TBL] [Abstract][Full Text] [Related]
6. Human group3 innate lymphoid cells express DR3 and respond to TL1A with enhanced IL-22 production and IL-2-dependent proliferation.
Ahn YO; Weeres MA; Neulen ML; Choi J; Kang SH; Heo DS; Bergerson R; Blazar BR; Miller JS; Verneris MR
Eur J Immunol; 2015 Aug; 45(8):2335-42. PubMed ID: 26046454
[TBL] [Abstract][Full Text] [Related]
7. Role of TL1A and its receptor DR3 in two models of chronic murine ileitis.
Bamias G; Mishina M; Nyce M; Ross WG; Kollias G; Rivera-Nieves J; Pizarro TT; Cominelli F
Proc Natl Acad Sci U S A; 2006 May; 103(22):8441-6. PubMed ID: 16698931
[TBL] [Abstract][Full Text] [Related]
8. The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases.
Meylan F; Davidson TS; Kahle E; Kinder M; Acharya K; Jankovic D; Bundoc V; Hodges M; Shevach EM; Keane-Myers A; Wang EC; Siegel RM
Immunity; 2008 Jul; 29(1):79-89. PubMed ID: 18571443
[TBL] [Abstract][Full Text] [Related]
9. The TNF-family ligand TL1A and its receptor DR3 promote T cell-mediated allergic immunopathology by enhancing differentiation and pathogenicity of IL-9-producing T cells.
Richard AC; Tan C; Hawley ET; Gomez-Rodriguez J; Goswami R; Yang XP; Cruz AC; Penumetcha P; Hayes ET; Pelletier M; Gabay O; Walsh M; Ferdinand JR; Keane-Myers A; Choi Y; O'Shea JJ; Al-Shamkhani A; Kaplan MH; Gery I; Siegel RM; Meylan F
J Immunol; 2015 Apr; 194(8):3567-82. PubMed ID: 25786692
[TBL] [Abstract][Full Text] [Related]
10. The TNF-family cytokine TL1A inhibits proliferation of human activated B cells.
Cavallini C; Lovato O; Bertolaso A; Pacelli L; Zoratti E; Zanolin E; Krampera M; Zamò A; Tecchio C; Cassatella MA; Pizzolo G; Scupoli MT
PLoS One; 2013; 8(4):e60136. PubMed ID: 23565196
[TBL] [Abstract][Full Text] [Related]
11. The TNF family member TL1A induces IL-22 secretion in committed human T
Thomas LS; Targan SR; Tsuda M; Yu QT; Salumbides BC; Haritunians T; Mengesha E; McGovern DP; Michelsen KS
J Leukoc Biol; 2017 Mar; 101(3):727-737. PubMed ID: 27733581
[TBL] [Abstract][Full Text] [Related]
12. Induction of interleukin-10 in the T helper type 17 effector population by the G protein coupled estrogen receptor (GPER) agonist G-1.
Brunsing RL; Prossnitz ER
Immunology; 2011 Sep; 134(1):93-106. PubMed ID: 21722102
[TBL] [Abstract][Full Text] [Related]
13. TL1A as a Potential Local Inducer of IL17A Expression in Colon Mucosa of Inflammatory Bowel Disease Patients.
Ślebioda TJ; Bojarska-Junak A; Stanisławowski M; Cyman M; Wierzbicki PM; Roliński J; Celiński K; Kmieć Z
Scand J Immunol; 2015 Oct; 82(4):352-60. PubMed ID: 26072972
[TBL] [Abstract][Full Text] [Related]
14. TL1A produced by lamina propria macrophages induces Th1 and Th17 immune responses in cooperation with IL-23 in patients with Crohn's disease.
Kamada N; Hisamatsu T; Honda H; Kobayashi T; Chinen H; Takayama T; Kitazume MT; Okamoto S; Koganei K; Sugita A; Kanai T; Hibi T
Inflamm Bowel Dis; 2010 Apr; 16(4):568-75. PubMed ID: 19834969
[TBL] [Abstract][Full Text] [Related]
15. A Novel Role for TL1A/DR3 in Protection against Intestinal Injury and Infection.
Jia LG; Bamias G; Arseneau KO; Burkly LC; Wang EC; Gruszka D; Pizarro TT; Cominelli F
J Immunol; 2016 Jul; 197(1):377-86. PubMed ID: 27233964
[TBL] [Abstract][Full Text] [Related]
16. Dominant role for TL1A/DR3 pathway in IL-12 plus IL-18-induced IFN-gamma production by peripheral blood and mucosal CCR9+ T lymphocytes.
Papadakis KA; Zhu D; Prehn JL; Landers C; Avanesyan A; Lafkas G; Targan SR
J Immunol; 2005 Apr; 174(8):4985-90. PubMed ID: 15814728
[TBL] [Abstract][Full Text] [Related]
17. Oestrogen-deficiency induces bone loss by modulating CD14
Collins FL; Stone MD; Turton J; McCabe LR; Wang ECY; Williams AS
BMC Musculoskelet Disord; 2019 Jul; 20(1):326. PubMed ID: 31299941
[TBL] [Abstract][Full Text] [Related]
18. TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease.
Pappu BP; Borodovsky A; Zheng TS; Yang X; Wu P; Dong X; Weng S; Browning B; Scott ML; Ma L; Su L; Tian Q; Schneider P; Flavell RA; Dong C; Burkly LC
J Exp Med; 2008 May; 205(5):1049-62. PubMed ID: 18411337
[TBL] [Abstract][Full Text] [Related]
19. TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation.
Takedatsu H; Michelsen KS; Wei B; Landers CJ; Thomas LS; Dhall D; Braun J; Targan SR
Gastroenterology; 2008 Aug; 135(2):552-67. PubMed ID: 18598698
[TBL] [Abstract][Full Text] [Related]
20. TL1A (TNFSF15) and DR3 (TNFRSF25): A Co-stimulatory System of Cytokines With Diverse Functions in Gut Mucosal Immunity.
Valatas V; Kolios G; Bamias G
Front Immunol; 2019; 10():583. PubMed ID: 30972074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
